Randomized, Double-blind, Multi-center, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Pneumostem Versus a Control Group for Treatment of Bronchopulmonary Dysplasia in Premature Infants

Trial Profile

Randomized, Double-blind, Multi-center, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Pneumostem Versus a Control Group for Treatment of Bronchopulmonary Dysplasia in Premature Infants

Completed
Phase of Trial: Phase II

Latest Information Update: 25 Apr 2017

At a glance

  • Drugs Mesenchymal stem cell therapy (Primary)
  • Indications Bronchopulmonary dysplasia
  • Focus Therapeutic Use
  • Sponsors Medipost
  • Most Recent Events

    • 18 Apr 2017 Status changed from active, no longer recruiting to completed.
    • 08 Apr 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.
    • 03 Sep 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top